Covered recipient · General Payments record
ANIKET NATEKAR
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$4,560.53
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,752.64 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $347.78 | 4 |
| ABBVIE INC. | $341.99 | 11 |
| EISAI INC. | $334.93 | 3 |
| PFIZER INC. | $132.63 | 3 |
| Neurelis, Inc. | $119.54 | 1 |
| Amneal Pharmaceuticals LLC | $111.54 | 1 |
| Curonix LLC | $103.81 | 1 |
| UCB, Inc. | $101.12 | 1 |
| Eli Lilly and Company | $87.63 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $71.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.85 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103297 | CMS |
| ABBVIE INC. | $12.50 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103299 | CMS |
| ABBVIE INC. | $4.30 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103301 | CMS |
| ABBVIE INC. | $8.05 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103303 | CMS |
| ABBVIE INC. | $6.71 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103305 | CMS |
| ABBVIE INC. | $9.00 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103307 | CMS |
| ABBVIE INC. | $15.00 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103309 | CMS |
| ABBVIE INC. | $24.44 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103311 | CMS |
| ABBVIE INC. | $6.67 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103313 | CMS |
| ABBVIE INC. | $120.79 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103315 | CMS |
| ABBVIE INC. | $124.68 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105103317 | CMS |
| Amneal Pharmaceuticals LLC | $111.54 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139196270 | CMS |
| Curonix LLC | $103.81 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132910773 | CMS |
| Eisai Inc. | $102.04 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110729881 | CMS |
| Eisai Inc. | $121.20 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110729879 | CMS |
| Eisai Inc. | $111.69 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110729883 | CMS |
| Eli Lilly and Company | $87.63 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136039305 | CMS |
| Lilly USA, LLC | $84.60 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136041690 | CMS |
| Lilly USA, LLC | $121.55 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135999243 | CMS |
| Lilly USA, LLC | $20.50 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136043446 | CMS |
| Lilly USA, LLC | $121.13 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136045821 | CMS |
| Neurelis, Inc. | $119.54 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145649186 | CMS |
| PFIZER INC. | $38.40 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131583257 | CMS |
| PFIZER INC. | $2.55 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131423324 | CMS |
| PFIZER INC. | $91.68 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131624817 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $71.67 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137641796 | CMS |
| UCB, Inc. | $101.12 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143447795 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.